Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer

por Plantinga, Theo S., Tesselaar, Marika H., Morreau, Hans, Corssmit, Eleonora P. M., Willemsen, Brigith K., Kusters, Benno, van Engen-van Grunsven, A. C. H., Smit, Johannes W. A., Netea-Maier, Romana T.
Publicado 2016

IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer

por Crezee, Thomas, Tesselaar, Marika H., Jaeger, Martin, Rabold, Katrin, Corver, Willem E., Morreau, Hans, Van Engen-Van Grunsven, Adriana C.H., Smit, Jan W.A., Netea-Maier, Romana T., Plantinga, Theo S.
Publicado 2021

Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non‐medullary thyroid cancer

por Crezee, Thomas, Tesselaar, Marika H., Nagarajah, James, Corver, Willem E., Morreau, Johannes, Pritchard, Catrin, Kimura, Shioko, Kuiper, Josephina G., van Engen-van Grunsven, Ilse, Smit, Jan W. A., Netea-Maier, Romana T., Plantinga, Theo S.
Publicado 2021

Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages

por Arts, Rob J. W., Plantinga, Theo S., Tuit, Sander, Ulas, Thomas, Heinhuis, Bas, Tesselaar, Marika, Sloot, Yvette, Adema, Gosse J., Joosten, Leo A. B., Smit, Johannes W. A., Netea, Mihai G., Schultze, Joachim L., Netea-Maier, Romana T.
Publicado 2016